The effects of coconut oil intake on metabolic disorders and fatty liver disease in mice
Journal of Nutritional Science · 2025
DOI: 10.1017/jns.2025.10032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nutritional Science, 2025. Verfasst von Madoka Sumi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Coconut Oil, Fatty Liver, Plant Oils, Metabolic Diseases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High-fat diets are closely implicated in the pathogenesis of chronic conditions, including obesity and hepatic steatosis. Recently, coconut oil, which is rich in medium-chain fatty acids, has attracted significant attention for its potential anti-obesity and anti-inflammatory properties. This study aimed to evaluate the effects of medium-chain fatty acids derived from coconut oil on metabolic disorders, particularly fatty liver, using a mouse model established by a high-fat diet. C57BL/6J mice were assigned to either the lard diet group or the coconut oil diet group and fed for 12 weeks. Glucose tolerance was assessed, and biochemical parameters, liver histology, and gene expression in the liver were analysed. Additionally, the concentrations of medium-chain fatty acids within the liver were determined through gas chromatography-mass spectrometry analysis. Mice fed a coconut oil diet exhibited suppressed weight gain and improved glucose tolerance compared to mice fed a lard diet. Furthermore, the coconut oil diet resulted in reduced hepatic fat accumulation, decreased expression levels of genes implicated in inflammation and lipid metabolism within the liver, and higher concentrations of medium-chain fatty acids in the liver. Coconut oil may contribute to the suppression of hepatic fat accumulation in the liver and the prevention of non-alcoholic fatty liver disease/metabolic dysfunction-associated steatotic liver disease by increasing the levels of medium-chain fatty acids in the liver and suppressing the expression of genes implicated in inflammation and lipid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Diabetes and Endocrinology, Kyoto Okamoto Memorial Hospital, Kyoto, Japan.
- AiSTI Science Co., Ltd., Wakayama, Japan.
ORCID-Profile: Madoka Sumi
Zitieren
APA
Sumi, M., Hasegawa, Y., Matsuyama, T., Miyoshi, T., Nakajima, H., Okamura, T., Nakanishi, N., Sasano, R., Hamaguchi, M., & Fukui, M. (2025). The effects of coconut oil intake on metabolic disorders and fatty liver disease in mice. Journal of Nutritional Science. https://doi.org/10.1017/jns.2025.10032
Vancouver
Sumi M, Hasegawa Y, Matsuyama T, Miyoshi T, Nakajima H, Okamura T, et al. The effects of coconut oil intake on metabolic disorders and fatty liver disease in mice. Journal of Nutritional Science. 2025. doi:10.1017/jns.2025.10032
BibTeX
@article{Sumi2025,
author = {Sumi, Madoka and Hasegawa, Yuka and Matsuyama, Tomoyuki and Miyoshi, Tomoki and Nakajima, Hanako and Okamura, Takuro and Nakanishi, Naoko and Sasano, Ryoichi and Hamaguchi, Masahide and Fukui, Michiaki},
title = {The effects of coconut oil intake on metabolic disorders and fatty liver disease in mice},
journal = {Journal of Nutritional Science},
year = {2025},
doi = {10.1017/jns.2025.10032}
}
EUVIMED